Skip to main content

Research Reports on, Cronos Group, Antibe Therapeutics, Emerald Health Therapeutics, and BriaCell Therapeutics

LONDON, UK / ACCESSWIRE / February 16, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: Cronos Group, Antibe Therapeutics, Emerald Health Therapeutics, and BriaCell Therapeutics. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index progressed 79.39 points, or 0.52%, to close Thursday's trading session at 15,407.66. The TSX Venture Exchange shaved off 1.97 points, or 0.24%, to finish at 834.20.

Moreover, the Healthcare index was up by 0.71%, closing at 89.17.

Today's stocks of interest consist of: Cronos Group Inc. (TSXV: MJN), Antibe Therapeutics Inc. (TSXV: ATE), Emerald Health Therapeutics Inc. (TSXV: EMH), and BriaCell Therapeutics Corporation (TSXV: BCT).

Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

Cronos Group Inc.

Toronto, Canada-based Cronos Group Inc.'s stock lost 5.00%, to finish Thursday's session at $9.50 with a total volume of 534,269 shares traded. Over the last three months and the previous year, Cronos' shares have rallied 124.06% and 295.83%, respectively. Shares of the Company, which formerly known as PharmaCan Capital Corp., seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations, are trading above its 200-day moving average. Cronos' 50-day moving average of $9.89 is above its 200-day moving average of $4.89. View the research report on MJN.V at:

www.active-investors.com/registration-sg/?symbol=MJN

Antibe Therapeutics Inc.

On Thursday, shares in Toronto, Canada Toronto, Canada Antibe Therapeutics Inc. ended the session 3.85% lower at $0.25 with a total volume of 636,521 shares traded. Antibe Therapeutics' shares have surged 35.13% in the last month and 177.78% in the previous three months. Furthermore, the stock has gained 13.64% in the past year. Shares of the Company, which together with its subsidiaries, originates, develops, and out-licenses patent protected pharmaceuticals primarily in Canada, Europe, and the US, are trading above its 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $0.20 is greater than its 200-day moving average of $0.12. Get the free report on ATE.V at:

www.active-investors.com/registration-sg/?symbol=ATE

Emerald Health Therapeutics Inc.

Victoria, Canada headquartered Emerald Health Therapeutics Inc.'s stock closed the day 7.20% lower at $5.80. The stock recorded a trading volume of 1.13 million shares. Emerald Health Therapeutics' shares have rallied 136.73% in the past three months and 353.13% in the previous year. Shares of the Company, which together with its subsidiaries, produces and sells medical marihuana and cannabis oils in Canada, are trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $6.87 is greater than its 200-day moving average of $3.38. Access the most recent report coverage on EMH.V at:

www.active-investors.com/registration-sg/?symbol=EMH

BriaCell Therapeutics Corp.

On Thursday, shares in West Vancouver, Canada headquartered BriaCell Therapeutics Corp. recorded a trading volume of 21,500 shares. The stock ended the day flat at $0.11. Shares of the Company, which engages in the research and development of cancer immunotherapy technology in Canada, are trading below its 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $0.14 is greater than its 50-day moving average of $0.13. Today's complimentary report on BCT.V can be accessed at:

www.active-investors.com/registration-sg/?symbol=BCT

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.